14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
May 01, 2024 Buy 26 920 Mirza Nadeem Q. Stock Options (Right to Purchase)
May 01, 2024 Buy 6 730 Mirza Nadeem Q. Common Stock
May 01, 2024 Buy 2 250 Mirza Nadeem Q. Stock Option (Right to Buy)
Mar 28, 2024 Buy 3 365 Hamill John P. Common Stock
Mar 28, 2024 Buy 13 460 Hamill John P. Stock Options (Right to Buy)
Mar 28, 2024 Buy 6 725 Gilad Oren Common Stock
Mar 28, 2024 Buy 26 900 Gilad Oren Stock Options (Right to Buy)
Mar 13, 2024 Buy 1 010 Hamill John P. Common Stock
Mar 13, 2024 Buy 505 Hamill John P. Tranche A Warrant
Mar 13, 2024 Buy 505 Hamill John P. Tranche B Warrant
Mar 13, 2024 Buy 6 860 Seizinger Bernd R. Common Stock
Mar 13, 2024 Buy 3 430 Seizinger Bernd R. Tranche A Warrant
Mar 13, 2024 Buy 3 430 Seizinger Bernd R. Tranche B Warrant
Mar 13, 2024 Buy 6 860 Henneman John B Iii Common Stock
Mar 13, 2024 Buy 3 430 Henneman John B Iii Tranche A Warrant
Mar 13, 2024 Buy 3 430 Henneman John B Iii Tranche B Warrant
Mar 13, 2024 Buy 2 000 Gilad Oren Common Stock
Mar 13, 2024 Buy 1 000 Gilad Oren Tranche A Warrant
Mar 13, 2024 Buy 1 000 Gilad Oren Tranche B Warrant
Aug 23, 2023 Buy 500 Pamukcu Rifat Common Stock
Aug 23, 2023 Buy 2 000 Pamukcu Rifat Stock Options (Right to Buy)
Aug 23, 2023 Buy 2 000 Grissinger Michael Stock Options (Right to Buy)
Aug 23, 2023 Buy 500 Grissinger Michael Common Stock
Aug 23, 2023 Buy 2 000 Henneman John B Iii Stock Options (Right to Buy)
Aug 23, 2023 Buy 500 Henneman John B Iii Common Stock
Aug 23, 2023 Buy 2 000 Peters Richard Stock Options (Right to Buy)
Aug 23, 2023 Buy 500 Peters Richard Common Stock
Aug 23, 2023 Buy 500 Duey Marc Common Stock
Aug 23, 2023 Buy 2 000 Duey Marc Stock Options (Right to Buy)
Aug 23, 2023 Buy 500 Seizinger Bernd R. Common Stock
Aug 23, 2023 Buy 2 000 Seizinger Bernd R. Stock Options (Right to Buy)
Aug 23, 2023 Buy 12 500 Bizzari Jean-pierre Stock Options (Right to Buy)
Aug 23, 2023 Buy 0 Bizzari Jean-pierre
Jun 07, 2023 Buy 6 029 Seizinger Bernd R. Common Stock
Jun 06, 2023 Buy 4 068 Seizinger Bernd R. Common Stock
May 05, 2023 Buy 12 500 Gruia Gabriela Stock Options (Right to Buy)
May 05, 2023 Buy 0 Gruia Gabriela
Mar 09, 2023 Buy 4 000 Gilad Oren Common Stock
Mar 09, 2023 Buy 16 000 Gilad Oren Stock Options (Right to Buy)
Feb 27, 2023 Buy 1 000 Hamill John P. Common Stock
Jan 30, 2023 Buy 539 758 Hamill John P. Employee Stock Option (Right to Buy)
Jan 30, 2023 Buy 269 879 Hamill John P. Common Stock
Jan 30, 2023 Buy 0 Hamill John P.
Jan 30, 2023 Buy 0 Hamill John P.
Aug 23, 2022 Buy 49 280 Pamukcu Rifat Common Stock
Aug 23, 2022 Buy 271 870 Pamukcu Rifat Common Stock
Aug 23, 2022 Sell 27 187 Pamukcu Rifat Series A Non-Voting Convertible Preferred Stock
Aug 23, 2022 Buy 4 009 690 Duey Marc Common Stock
Aug 23, 2022 Buy 11 610 Duey Marc Common Stock
Aug 23, 2022 Sell 1 161 Duey Marc Series A Non-Voting Convertible Preferred Stock
Aug 23, 2022 Buy 6 045 100 Gilad Oren Common Stock
Aug 23, 2022 Sell 604 510 Gilad Oren Series A Non-Voting Convertible Preferred Stock
Jul 28, 2022 Buy 5 995 Seizinger Bernd R. Common Stock
Jul 28, 2022 Buy 29 575 Seizinger Bernd R. Stock Option (right to Buy)
Jul 28, 2022 Buy 32 400 Schade Christian S Common Stock
Jul 28, 2022 Buy 47 600 Schade Christian S Stock Option (right to Buy)
Jul 28, 2022 Buy 29 575 Peters Richard Stock Option (right to Buy)
Jul 28, 2022 Buy 5 995 Peters Richard Common Stock
Jul 28, 2022 Buy 24 300 Korbel Gregory Alan Common Stock
Jul 28, 2022 Buy 35 700 Korbel Gregory Alan Stock Option (right to Buy)
Jul 28, 2022 Buy 29 575 Henneman John B Iii Stock Option (right to Buy)
Jul 28, 2022 Buy 5 995 Henneman John B Iii Common Stock
Jul 28, 2022 Buy 29 575 Grissinger Michael Stock Option (right to Buy)
Jul 28, 2022 Buy 5 995 Grissinger Michael Common Stock
Jul 28, 2022 Buy 60 800 Coiante Scott M Common Stock
Jul 28, 2022 Buy 89 200 Coiante Scott M Stock Option (right to Buy)
Jun 03, 2022 Sell 65 770 Schade Christian S Common Stock
Jun 03, 2022 Sell 35 284 Coiante Scott M Common Stock
Jun 03, 2022 Sell 8 390 Korbel Gregory Alan Common Stock
May 18, 2022 Buy 50 000 Seizinger Bernd R. Common Stock
May 18, 2022 Buy 37 500 Schade Christian S Common Stock
May 16, 2022 Buy 72 638 Grissinger Michael Stock Option (right to buy)
Mar 10, 2022 Buy 427 700 Schade Christian S Stock Option (right to Buy)
Mar 10, 2022 Buy 100 100 Schade Christian S Common Stock
Mar 10, 2022 Buy 72 600 Korbel Gregory Alan Stock Option (right to Buy)
Mar 10, 2022 Buy 16 000 Korbel Gregory Alan Common Stock
Mar 10, 2022 Sell 1 989 Korbel Gregory Alan Common Stock
Mar 10, 2022 Buy 185 900 Coiante Scott M Stock Option (right to Buy)
Mar 10, 2022 Buy 42 900 Coiante Scott M Common Stock
Mar 10, 2022 Buy 100 000 Abrahmsen Lars B. Stock Option (right to Buy)
Mar 10, 2022 Buy 24 700 Abrahmsen Lars B. Common Stock
Feb 25, 2022 Sell 21 644 Schade Christian S Common Stock
Feb 25, 2022 Sell 1 326 Korbel Gregory Alan Common Stock
Feb 25, 2022 Sell 14 817 Coiante Scott M Common Stock
Dec 01, 2021 Buy 27 500 Korbel Gregory Alan Common Stock
Dec 01, 2021 Sell 27 500 Korbel Gregory Alan Common Stock
Dec 01, 2021 Sell 27 500 Korbel Gregory Alan Stock Option (right to Buy)
Nov 01, 2021 Buy 27 500 Korbel Gregory Alan Common Stock
Nov 01, 2021 Sell 2 255 Korbel Gregory Alan Stock Option (right to Buy)
Nov 01, 2021 Sell 27 500 Korbel Gregory Alan Common Stock
Nov 01, 2021 Sell 25 245 Korbel Gregory Alan Stock Option (right to Buy)
Oct 01, 2021 Buy 50 000 Abrahmsen Lars B. Common Stock
Oct 01, 2021 Sell 50 000 Abrahmsen Lars B. Stock Option (right to Buy)
Oct 01, 2021 Sell 50 000 Abrahmsen Lars B. Common Stock
Oct 01, 2021 Buy 27 500 Korbel Gregory Alan Common Stock
Oct 01, 2021 Sell 27 500 Korbel Gregory Alan Stock Option (right to Buy)
Oct 01, 2021 Sell 27 500 Korbel Gregory Alan Common Stock
Sep 20, 2021 Sell 27 500 Korbel Gregory Alan Stock Option (right to Buy)
Sep 20, 2021 Buy 27 500 Korbel Gregory Alan Common Stock
Sep 20, 2021 Sell 27 500 Korbel Gregory Alan Common Stock
INSIDER POWER
89.614
Last 100 transactions
Buy: 13 110 412 | Sell: 1 102 078 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 89.614.

In total, the insiders bought 13 110 412 and sold 1 102 078 APRE shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Aprea Therapeutics Inc.

Aprea Therapeutics. Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATR... APRE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT